Given the significant roles of aspartate in amino acid and nucleotide synthesis, and of citrate in de novo lipogenesis, our results support the hypothesis that SLC25A21 downregulation accelerates Gln-derived biosynthesis in KRAS-mutant CRC cells. The gene discussed is SLC25A21; the disease is colorectal carcinoma.